Glazer Capital LLC’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Glazer Capital LLC’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-607,345	Closed	-$12.1M	–	795
2022 Q3	$12.1M	Buy	+607,345	New	+$8.01M	0.22%	146

Glazer Capital LLC's FMTX Position: Q4 2022 in Review

Glazer Capital LLC sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 607,345 shares — an estimated $12.1M sold.

Glazer Capital LLC first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $12.1M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Glazer Capital LLC reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 607,345 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $12.1M.
Glazer Capital LLC first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Glazer Capital LLC's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $12.1M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.